Ticagrelor versus clopidogrel in dual antiplatelet therapy after minor stroke or transient ischemic attack: an updated network meta-analysis.
Gabriel Marinheiro Dos Santos BezerraBeatriz AraújoGabriel de Almeida MonteiroMarianna LeiteAntonio MutarelliArtur Menegaz de AlmeidaJoaquim Francisco Cavalcante-NetoAndré RiveraAgostinho Camara PinheiroJoão Paulo Motta TellesPublished in: Journal of neurology (2024)
DAPTs were superior to aspirin in preventing recurrence or ischemic stroke. Although no significant difference was observed between DAPTs, ticagrelor plus aspirin may be related to worse major bleeding results, including intracranial bleeding. Ticagrelor plus aspirin is a considerable option for patients after a minor stroke or TIA.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- atrial fibrillation
- acute coronary syndrome
- st segment elevation myocardial infarction
- systematic review
- st elevation myocardial infarction
- end stage renal disease
- cerebral ischemia
- coronary artery disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- low dose
- randomized controlled trial
- prognostic factors
- peritoneal dialysis
- cardiovascular events
- cardiovascular disease
- meta analyses
- oxidative stress
- brain injury
- patient reported outcomes
- type diabetes
- optic nerve